A detailed history of Vanguard Group Inc transactions in Generation Bio Co. stock. As of the latest transaction made, Vanguard Group Inc holds 2,635,722 shares of GBIO stock, worth $3.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,635,722
Previous 2,588,572 1.82%
Holding current value
$3.69 Million
Previous $7.3 Million 10.81%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$2.16 - $3.51 $101,844 - $165,496
47,150 Added 1.82%
2,635,722 $6.51 Million
Q2 2024

Aug 13, 2024

BUY
$2.64 - $4.35 $47,826 - $78,804
18,116 Added 0.7%
2,588,572 $7.3 Million
Q1 2024

May 10, 2024

BUY
$1.73 - $4.07 $31,494 - $74,094
18,205 Added 0.71%
2,570,456 $10.5 Million
Q4 2023

Feb 14, 2024

BUY
$0.91 - $3.35 $194,254 - $715,114
213,467 Added 9.13%
2,552,251 $4.21 Million
Q3 2023

Nov 14, 2023

BUY
$3.65 - $6.9 $290,266 - $548,722
79,525 Added 3.52%
2,338,784 $8.86 Million
Q2 2023

Aug 14, 2023

BUY
$3.5 - $5.67 $58,131 - $94,173
16,609 Added 0.74%
2,259,259 $12.4 Million
Q1 2023

May 15, 2023

BUY
$3.61 - $7.01 $40,255 - $78,168
11,151 Added 0.5%
2,242,650 $9.64 Million
Q4 2022

Feb 10, 2023

BUY
$3.66 - $6.77 $47,495 - $87,854
12,977 Added 0.58%
2,231,499 $8.77 Million
Q3 2022

Nov 14, 2022

BUY
$4.68 - $8.34 $38,436 - $68,496
8,213 Added 0.37%
2,218,522 $11.8 Million
Q2 2022

Aug 12, 2022

SELL
$4.87 - $9.41 $6.52 Million - $12.6 Million
-1,338,868 Reduced 37.72%
2,210,309 $14.5 Million
Q1 2022

May 13, 2022

SELL
$4.16 - $7.76 $188,381 - $351,403
-45,284 Reduced 1.26%
3,549,177 $26.1 Million
Q4 2021

Feb 14, 2022

BUY
$5.99 - $24.97 $259,882 - $1.08 Million
43,386 Added 1.22%
3,594,461 $25.4 Million
Q3 2021

Nov 12, 2021

BUY
$20.0 - $27.43 $6.51 Million - $8.94 Million
325,749 Added 10.1%
3,551,075 $89 Million
Q2 2021

Aug 13, 2021

BUY
$24.34 - $38.34 $78.5 Million - $124 Million
3,225,326 New
3,225,326 $86.8 Million

Others Institutions Holding GBIO

About Generation Bio Co.


  • Ticker GBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,011,200
  • Market Cap $82.6M
  • Description
  • Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...
More about GBIO
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.